Mortality among patients with tuberculosis requiring intensive care: A retrospective cohort study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Silva, Denise R ^a   Menegotto, Diego M ^a   Schulz, Luis F ^a   Gazzana, Marcelo B ^a   Dalcin, Paulo T R ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; LIVER TOXICITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RETROSPECTIVE STUDY; VENTILATOR ASSOCIATED PNEUMONIA; COMORBIDITY; DEVELOPING COUNTRY; INTENSIVE CARE; MIDDLE AGED; TUBERCULOSIS; URBAN POPULATION;

ADULT; COHORT STUDIES; COMORBIDITY; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULOSIS; URBAN POPULATION;

EID: 77951191450     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-54     Document Type: Article

References (29)

1. Prefeitura Municipal de Porto Alegre. Boletim Epidemiológico. Porto Alegre, Brasil, 2008. , http://lproweb.procempa.com.br/pmpa/prefpoa/sms/usu_doc/boletim_n_35.pdf
2. World Health Organization. Global Tuberculosis Control. Report 2008. , http://www.who.int
3. Frame RN, Johnson MC, Eichenhorn MS, Bower GC, Popovich J. Active tuberculosis in the medical intensive care unit: a 15-year retrospective analysis. Crit Care Med 1987, 15:1012-1014. 10.1097/00003246-198711000-00005, 3677743.
4. Erbes R, Oettel K, Raffenberg M, Mauch H, Schimidt-Ioanas M, Lode H. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J 2006, 27:1223-1228. 10.1183/09031936.06.00088105, 16481385.
5. Lee PL, Jerng JS, Chang YL, Chen CF, Hsueh PR, Yu CJ, Yang PC, Luh KT. Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation. Eur Respir 2003, 22:141-147.
6. Penner C, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med 1995, 151(3 Pt 1):867-872.
7. Ryu YJ, Koh WJ, Kang EH, Suh GY, Chung MP, Kim H, Kwon OJ. Prognostic factors in pulmonary tuberculosis requiring mechanical ventilation for acute respiratory failure. Respirology 2007, 12:406-411. 10.1111/j.1440-1843.2006.01007.x, 17539846.
8. Sociedade Brasileira de Pneumologia e Tisiologia II Diretrizes Brasileiras para Tuberculose. J Bras Pneumol 2004, 30(Supl 1):S1-S86. Sociedade Brasileira de Pneumologia e Tisiologia.
9. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985, 202:685-693. 10.1097/00000658-198512000-00004, 1250999, 4073980.
11. American Thoracic Society Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. 10.1164/rccm.200405-644ST, 15699079, American Thoracic Society.
12. Zahar JR, Azoulay E, Klement E, De Lassance A, Lucet JC, Regnier B, Schlemmer B, Bedos JP. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 2001, 27:513-520. 10.1007/s001340000849, 11355119.
13. Greenaway C, Menzies D, Fanning A, Grewal R, Yuan L, FitzGerald JM. Delay in diagnosis among hospitalized patients with active tuberculosis - Predictors and outcomes. Am J Respir Crit Care Med 2002, 165:927-933.
14. Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996, 276:1223-1228. 10.1001/jama.276.15.1223, 8849749.
15. Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis 2004, 8:598-602.
16. Balabanova Y, Drobniewski F, Fedorin I, Zakharova S, Nicolayevskyy V, Atun R. The directly observed therapy short-course (DOTS) strategy in Samara Oblast, Russia Federation. Respir Res 2006, 7:44-54. 10.1186/1465-9921-7-44, 1440858, 16556324.
17. Dahmash NS, Arora SC, Fayed DF, Chowdhury MN. Infections in critically ill patients: experience in MICU at a major teaching hospital. Infection 1994, 22:264-270. 10.1007/BF01739913, 8002086.
18. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370. 10.1681/ASN.2004090740, 16177006.
19. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006.
20. Piqueras AR, Marruecos L, Artigas A, Rodriguez C. Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med 1987, 13:175-182. 10.1007/BF00254701, 3584648.
21. Stoneburner R, Laroche E, Prevots R, Singh T, Blum S, Terry P, Reatrice S, Adler J. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Arch Intern Med 1992, 152:2033-2037. 10.1001/archinte.152.10.2033, 1358042.
22. Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, Barnes PF. CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis 1997, 24:988-991.
23. Thompson J. The intestinal response to critical illness. Am J Gastroenterol 1995, 90:190-200.
24. Berning SE, Huitt GA, Iseman MD, Peloquin CA. Malabsorption of antituberculosis medications by a patient with AIDS [letter]. N Engl J Med 1992, 327:1817-1818.
25. Patel KB, Belmonte R, Crowe HM. Drug malabsorption and resistant tuberculosis in HIV-infected patients [letter]. N Engl J Med 1995, 332:336-337. 10.1056/NEJM199502023320518, 7816080.
26. Kimerling ME, Phillips P, Patterson P, Hall M, Robinson A, Dunlap NE. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest 1998, 113:1178-1183. 10.1378/chest.113.5.1178, 9596291.
27. Metha JB, Shantaveerapa H, Byrd RP, Morton SE, Fountain F, Roy TM. Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy. Chest 2001, 120:1520-1524. 10.1378/chest.120.5.1520, 11713129.
28. Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, Hodge T. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin Infect Dis 2005, 40:1481-1491. 10.1086/429321, 15844071.
29. Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman S, Oyewo A, Talbot EA, Kenyon TA, Moeti TL, Moffat HL, Peloquin CA. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin Infect Dis 2005, 41:461-469. 10.1086/431984, 16028152.